Sabrina B.
- Country
- France
- Department
- Service d'Hématologie Clinique Adultes et Thérapie Cellulaire
Research Overview
Data & Insights
Has run more than one trial at 0 of 85 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in advancing treatment approaches for myelofibrosis (MF), with particular emphasis on developing innovative therapeutic combinations for treatment-naïve patients.
- Primary Myelofibrosis Management
- Novel Therapeutic Combinations
- Targeted Treatment Strategies
A key focus lies in exploring selective inhibition of nuclear export mechanisms in hematologic malignancies.
Molecular Therapeutics
The investigator's work centers on evaluating targeted molecular therapies, particularly the clinical application of nuclear export inhibitors in combination with established treatments.
- Signal Transduction Pathways
- Combination Therapy Approaches
- Drug Resistance Mechanisms
Research interests include the development of novel therapeutic strategies for hematologic disorders.
Clinical Innovation
The investigator focuses on evaluating treatment efficacy and safety profiles in previously untreated myelofibrosis patients.
- First-line Treatment Strategies
- Safety Assessment Protocols
- Patient Response Evaluation
Expertise includes the assessment of therapeutic combinations in hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.